Tag Archives: Medicine

Huge Rise In Number Of Breast Surgery Enquiries Reports Surgicare

SurgiCare has revealed a large rise in the number of enquiries from patients in relation to breast surgery procedures, as well as an increase in the number of breast surgery consultations that have been carried out.

New data from SurgiCare has revealed that enquiries regarding breast augmentation have risen from 485 in March 2008 to 624 in March of this year. Moreover, the number of breast surgery consultations carried out by SurgiCare has also increased by 28% over the
past year.

These new breast surgery figures from SurgiCare support the trends reported by the British Association of Aesthetic Plastic Surgeons, who found that breast augmentation procedures rose by 30% from 6487 in 2007 to 8439 last year.

SurgiCare carried out 105 breast augmentations through its clinics across the UK in January but has already performed 183 procedures so far in April.

One of the main reasons cited for the rise in breast enlargement and augmentation procedures is women wanting to look their best on their wedding day. 60% of patients questioned said they were undergoing the procedure specifically to look good for their forthcoming wedding during the summer. Mark Bury, Chief Executive at SurgiCare, commented that the company had to turn away frantic women who had not left enough time to fully recover from the operation ahead of their wedding, with it taking close to six weeks to fully recover from breast surgery and about three months to see the best results. Macrolane treatments have proved to be a popular option for women who have this dilemma, as it is an injectable filler that increase the size of the breasts, making them softer and fuller instantly, at a significantly lower cost that other cosmetic surgeries.

About SurgiCare
SurgiCare is one of the largest and most respected cosmetic surgery networks in the UK. SurgiCare was established more than 16 years ago by a leading professor of surgery, now its medical director, who also chairs its in-house Medical Advisory Committee.

As one of the leading UK specialists in cosmetic treatments, SurgiCare has the experience, latest therapies and the caring, professional staff to enhance a patients self-confidence by improving appearances. SurgiCare prides itself on providing an unrivalled aftercare service with all surgeons registered on the General Medical Council Specialist Register, to ensure every patient receives the best possible standard in care and results.

SurgiCare has helped more than 20,000 patients fulfil their dreams of looking and feeling their best. SurgiCare also specialise in Weight Loss Surgery with a unique 24 month support programme and lifetime aftercare.

Via EPR Network
More Healthcare press releases

Breast Augmentation Surgery Is Still Top Of The Ops

The Harley Medical Group has reported a rise in breast augmentation surgery, with a growth of 27% year on year. This increase has been driven by a boom in post baby surgery, with mothers now accounting for 60% of breast augmentation patients, making it the third most common type of post-natal procedure.

Angela Fry, 38, from Maidenhead had a breast augmentation after she had her fourth child. She comments: “After each birth my shape changed dramatically and my breasts sagged and lost their shape completely. For me, having a Breast Augmentation wasn’t about getting bigger breasts but getting them back to the shape and size that was right for my figure. Having the surgery has made me feel more feminine and given me much more confidence in myself.”

Breast augmentation surgery was first performed in 1895 and is today the most popular surgical cosmetic procedure for women. During the procedure an incision is made in the crease of the underside of the breast and the implant is inserted into a pocket created by the surgeon. The result is fuller and more evenly shaped breasts. The treatment takes around one hour to perform and a general anaesthetic will be administered to the patient.

Breast augmentation surgery at The Harley Medical Group costs from £4,275. For more information visit the www.harleymedical.co.uk.

 

About The Harley Medical Group:
The Harley Medical Group is the UK’s largest cosmetic surgery provider, performing more procedures and with more clinics than any other cosmetic surgery provider. It has been established for over 25 years and is one of the most highly-regarded Cosmetic Surgery Groups operating in the UK. It has treated over 435,000 patients to date.

The Harley Medical Group works tirelessly to maintain the highest standards in the industry for the benefits all cosmetic surgery and non surgical patients. We are currently at the forefront of the campaign to ensure that the Government continues to regulate the use of certain laser types used in cosmetic surgery and non surgical treatments so that patients are protected from rogue practitioners.

All of The Harley Medical Group’s clinics are registered with the Healthcare Commission and there are now 26 clinics in the UK and Ireland: London (Harley Street, Wimbledon, The City, Chiswick, Finchley & Watford), Marlow, Birmingham, Leeds, Brighton, Bristol, Manchester, Newcastle, Chester, Nottingham, Southampton, Cardiff, Chelmsford, Dublin, Northampton, Cambridge, Maidstone, Belfast, Reading, Sheffield and Liverpool.

Via EPR Network
More Healthcare press releases

Lloydspharmacy Chief Urges Weight Loss Pills Must Be Sold With Care

Lloydspharmacy has warned customers that the weight loss treatment alli, which can now be sold in pharmacies without a prescription must be supplied only after a proper consultation, fearing that people may take it even though it’s not clinically appropriate for them to do so.

Andy Murdock, Pharmacy Relations and Governance Director of Lloydspharmacy, said: “It’s important that all sectors of the pharmacy profession uphold the very highest clinical standards when providing this treatment,” he said. “A number of GPs have said they are worried that alli weight loss treatment may be sold to people for whom it is clinically inappropriate.

“I am calling on all colleagues to maintain the very highest standards when the service begins tomorrow and not to let the desire to please the customer override clinical considerations.”

Lloydspharmacy has trained more than 3,000 pharmacists and healthcare assistants to sell the treatment.

alli can help people who are overweight to boost their weight loss by up to 50 per cent. So, for every 2lbs of weight lost through their own efforts, alli can help shed a further 1lb.

However, it is only appropriate for people who have a BMI of 28 or over and should only be sold to people who are happy to lose weight gradually, are ready to adopt a reduced calorie, lower-fat diet and eat smaller portions.

People who are on certain medications* should be referred to their GP and there are some important contra-indications**.

Dr Chris Steele, who is famous for helping a ‘This Morning’ viewer lose 30 stones, said: “alli is a proven weight loss treatment and I am pleased that it’s now available over the counter in pharmacies. It’s good to see that responsible pharmacy groups like Lloydspharmacy have trained their staff thoroughly so that the treatment is only sold to people for whom it’s appropriate.”

alli contains Orlistat, which has been available on prescription marketed as Xenical at 120mg for over 10 years. It helps to prevent the absorption of fat and allows excess fat from food consumed to pass naturally through the body.

“All customers who want to buy alli should have a proper private consultation with a pharmacy professional who has been trained to advise customers about the treatment,” added Murdock. “They should be given a record card with the first
purchase and present this each time they buy further courses.”

“It is not a miracle cure for obesity,” said Andy Murdock. “For people who are committed to losing weight and who are prepared to make the appropriate lifestyle changes, alli can provide a very significant additional benefit, but it’s not a magic bullet.”

* Amidorane, Acarbose, Fat soluble vitamins
** anti-coagulants, ciclosporin. Also, alli should not be sold to anyone under 18 or to pregnant or breast feeding women

About Lloydspharmacy
Lloydspharmacy has around 1700 pharmacies across the UK. These are based predominantly in community and health centre locations. The company employs over 16,000 staff and dispenses over 145 million prescription items annually.

Lloydspharmacy which is a community pharmacy has primary care at the heart of its business. This is why it has launched a range of products aimed at improving community health such as affordable blood pressure monitors and allergy relievers, as well as a suite of convenient professional health check services including free blood pressure and diabetes testing, and cholesterol and heart checks in the comfort of a private consultation room.

Lloydspharmacy is the trading name of Lloydspharmacy Ltd, a wholly owned subsidiary of Celesio AG based in Stuttgart. Celesio is the leading pharmaceutical distribution company in Europe and is represented in 16 countries. With its three divisions, Celesio Wholesale, Celesio Pharmacies and Celesio Solutions, the group covers the entire scope of pharmaceutical trade and pharmaceutical-related services.

Via EPR Network
More Healthcare press releases

ePharmaExpo.Com – A Central Source For Business News And Information For Everyone Associated With The Pharmaceutical And Life Sciences Industries

The recently launched ePharmaExpo.com website incorporates a virtual trade show, event postings, recruitment database, and forums to give everyone associated with the pharmaceutical and life sciences industries a central source for business news and information.

The launch of ePharmaExpo.com, a website encompassing multiple aspects of the pharmaceutical and life sciences industries, was recently announced. ePharmaExpo.com is designed to be a central information resource for businesses, vendors, employees, and job seekers within the pharmaceutical and life sciences industries.

The main draw of ePharmaExpo.com is expected to be the virtual trade show feature. This component of the website allows businesses to showcase their services and products through online booth displays, which take the place of traditional trade show booths. Businesses will have the opportunity to reach an undetermined number of Internet users year round and twenty-four hours a day instead of a limited number of trade show participants for a few days at a conventional industry trade show. Visitors can benefit from viewing products and services from their home or business instead of traveling to pharmaceutical and life sciences trade shows. ePharmaExpo.com owners hope to increase the quality of leads generated for the site’s exhibitors by offering a means to connect with interested parties.

Pharmaceutical and life sciences businesses, organizations, and universities from across the nation are able to post upcoming local events on ePharmaExpo.com. Newsworthy items such as information about industry-related conference and seminars and press releases are accepted.

ePharmaExpo.com can also be used as a source for businesses searching for qualified job applicants and for those seeking employment in the pharmaceutical and life sciences fields. Businesses can currently take advantage of the website’s introductory offer of free three-month job postings. The owners report that over one hundred positions have been posted since the launch of ePharmaExpo.com. A resume database allows companies to search for candidates with specific qualifications, decreasing their time and money spent recruiting qualified candidates. Job seekers can post their resumes and search for employment opportunities by state.

A discussion forum allows ePharmaExpo.com visitors to communicate anonymously with other visitors and the website exhibitors. Visitors can post comments and questions, exchange information, and seek the advice of other forum users. ePharmaExpo.com administrators have future plans for an anonymous messaging system, which will allow visitors to ask questions directly to the site’s exhibitors without revealing their identities. The intention of this feature is to promote a more relaxed atmosphere for visitors that allows for an exchange of information without disclosing personal data.

About ePharmaExpo.com: ePharmaExpo.com is a virtual trade show website for the pharmaceutical and life sciences industries. The website features exhibitions of products and services, discussion forums, and industry job postings and events. Contact Chi-chau Tse at 619-808-3773 or tse@ePharmaExpo.com for more information.

Via EPR Network
More Healthcare press releases

Surgicare Introduces New Vaser Lipo Procedure In Response To A Huge Rise In Smartlipo Enquiries

Following a first quarter year on year increase of 375% in the number of enquiries for SmartLipo through Surgicare, the cosmetic surgery network has announced the introduction of their new Vaser Lipo procedure.

SurgiCare’s current SmartLipo procedure is a revolutionary concept in fat removal, using laser technology to melt fat cells and provide immediately visible results. The introduction of Vaser Lipo technology leads to more selective and gentle procedure that reduces possible swelling and bruising, producing a shorter recovery period.

Liposuction has been around as a favourite body contouring surgical procedure since the 1980s, however a few years ago the technique of SmartLipo, was introduced as a form of Liposuction without the suction to help reduce recovery times. SmartLipo uses a fine fibre optic laser to break up fat deposits which are then gradually reabsorbed by the body over the next 6 to 12 weeks.

Vaser, which stands for Vibration Amplification of Sound Energy at Resonance, is an ultrasound assisted form of Liposuction developed by Sound Surgical Technologies in Utah. Vaser utilizes fine probes which include engineered grooves to help control and restrict the effects of the ultrasound to targeting just the fat and not the surrounding cells, as well as reducing any potential bleeding.

Mark Bury, CEO at Surgicare, said, “Surgicare is always looking for ways to improve patient care and reduce recovery times. The introduction of the new Vaser Lipo procedure will mean even better results for patient and represents a major step forward. With the increase in the number of enquiries which we have already received for SmartLipo procedures this year, we expect to be very busy in the run up to the summer holidays.”

About SurgiCare
SurgiCare is one of the largest and most respected cosmetic surgery networks in the UK. SurgiCare was established more than 16 years ago by a leading professor of surgery, now its medical director, who also chairs its in-house Medical Advisory Committee.

As one of the leading UK specialists in cosmetic treatments, SurgiCare has the experience, latest therapies and the caring, professional staff to enhance a patients self-confidence by improving appearances. SurgiCare prides itself on providing an unrivalled aftercare service with all surgeons registered on the General Medical Council Specialist Register, to ensure every patient receives the best possible standard in care and results.

SurgiCare has helped more than 20,000 patients fulfil their dreams of looking and feeling their best. SurgiCare also specialise in Weight Loss Surgery with a unique 24 month support programme and lifetime aftercare.

Via EPR Network
More Healthcare press releases

An International Panel Of Physicians Reports About A Special Way Of Healing On The Spiritual Path

An extraordinary series of lectures will be held in Fairfax, VA (near Washington, DC) and Los Angeles, CA in May, 2009. Seven Medical specialists from four countries will report about a free special way of healing for everyone. Medical doctors, veterinarians and psychologists from Europe, America, Asia, Australia and Africa have formed the Medical Scientific Group of Specialists (MWF). The task of this group, which belongs to the Bruno Groening Circle of Friends, is to record and verify healings the spiritual way. A compilation of more than 200 concise healing reports can be found on our web site: www.bruno-groening.org/english/ under the link Healings.

The international panel of physicians includes:

G. Blaettner, M.D., Germany,Board Cert. ENT
M. Galante, M.D., USA
L. Colizoli, M.D., USA, Board Cert. Psych.
K. Winchester, M.D.,USA Board Cert., Opthal.
Prof. G. Beketova, M.D., Ph.D., Ukraine, Board Cert. Pediatrics, Prof.Univ. of Kiev
R. Friewald, M.D., D.V.M., Germany
F. Gringinger, M.D., D.O., Austria, Board Cert. Family Prac.
R. Leo, USA

They will speak about their experiences on the following dates.

Saturday, May 2, 2009 at 3 – 7 pm 
(incl. 30 min. break):

George Mason University, 
Fairfax Campus
Lecture Hall, Room 1
4400 University Drive
Fairfax, VA 22030
Contact: Mrs. Heidi Gewehr at 571-313-0267 or h.gewehr@web.de
*Sunday, May 3, 2009 ~ 3 -7 pm 
(incl. 30 min. break)*:

Anderson School of Management, UCLA 
(park in structure 4)
Korn Convocation Hall – C Building 
110 Westwood Plaza
Los Angeles, CA 90095
Contact: Chris Runge at 323.394.4691 or chrismwf.info@yahoo.com

During these lectures, physicians will talk about persons who have experienced healing and freedom from long lasting, severe and chronic diseases in a miraculous way. Medical documents will be presented; the experts will explain the intricacies of a superior healing power that has been widely forgotten in modern medicine. The teachings of Bruno Groening (1906-1959), who became world famous due to extraordinary healings in the fifties, are taken as a basis for the lectures. Bruno Groening said time and again: “There is no incurable – God is the greatest physician”. He spoke about a higher power that he called the healing stream, life power or divine energy. This power is abundantly available for everyone. The knowledge about how to make use of this power is passed on free of charge in the worldwide non-profit, volunteer based organization of the Bruno Groening Circle of Friends.

The work of the MWF is supported by some well-known people in the United States, e.g. Dr. Christiane Northrup and Dr. Carl Simonton. Link to information online: http://www.bruno-groening.org/english/lectures2009.htm.

Via EPR Network
More Healthcare press releases

Wrongful Convictions Of Physicians By Department Of Health (NYSDOH) Linked To Patient Mortality

The proliferation of wrongful convictions in New York State prompted the NYS Bar Association to create a Blue Ribbon task force to study its systemic, procedural and statutory causes, and to propose solutions. Indeed, a report by the Innocence Project found New York State to be the national leader, outpacing all other states in its rate of wrongful convictions. The Blue Ribbon findings, embodied in a document entitled “ Final Report of the New York State Bar Association’s Task Force on Wrongful Convictions” was unanimously endorsed by the Association’s House of Delegates on April 4.

The findings of the Task Force provide a disturbing commentary on flagrant errors by the New York State judicial system, leading to convictions of innocent individuals. In over 50% of cases, the failures of government practices – such as misconduct by prosecutors – were to blame for the wrongful convictions.

Wrongful convictions do not solely implicate the New York State criminal justice system. They are reportedly rife in the legal practices of the NYS Department of Health (NYSDOH), known for ignoring due process and abusing power in its disciplinary actions against physicians. Several bills aiming to redress these inequities were all vetoed. Reported among many of these due process violations is the denying of witnesses for phy sicians’ defense, the use of tainted judges, and the coaching of plaintiffs by prosecutors to lie – indeed, “winning” cases is vital for their career advancement. Especially targeted in these malicious prosecutions are physicians practicing complementary medicine. One physician who wished to remain anonymous for fear of retribution remarked, “Convicting doctors is a cinch: just don’t allow them any witnesses; then the Department is free to make up whatever it wants.”

The tragedy of wrongful convictions in matters of health care affects far more than physicians. The plight of patients suddenly obliged to forgo the continuity of their medical care by the forcible removal of their long term physicians via the challenging of their license is illustrated in press and Internet releases entitled, “Patient Mortality Linked to Judicial Errors.” Noted are certain fragile patients who, “vulnerable, sick, alone, frightened and suddenly deprived of their main lifeline (their physician), became acutely demoralized, refused referrals to other doctors or failed to bond with them, eventually giving up their will to live and neglecting their medical needs.” One physician reported the untimely deaths of 7 patients, including one from suicide, the rapid decline of 8 Alzheimer’s and the relapses of 12 psychiatric patients leading to their serial hospitalizations.”

In response, petitions have now been forwarded to agencies concerned with patient20welfare, calling for independent impact studies on state-ordered patient abandonment. Agencies contacted include the U.S. Health and Human Services Administration (HHS) and the Centers for Medicare and Medicaid. The petition has also been sent to Health Commissioner Richard F. Daines, NYSDOH.

This landmark study, of major interest to medical, psychiatric and medico-legal communities and the public at large, would aim to show that abruptly severing medical and psychiatric services by state agencies has serious and sometimes fatal consequences for patients – especially patients who are disadvantaged, infirm, chronically ill or psychiatrically disabled. It would also suggest remedial action. Indeed, if state agencies assume the power of terminating the basic care to patients provided for by their physicians, they presumably also should accept the responsibility for adequately supporting said patients through crisis, by providing them with life-saving continuity of care.

Via EPR Network
More Healthcare press releases

Advanced Technology Laser Company Receives 510(k) for Its Cosmetic IPL Skin Therapy System

Advanced Technology Laser Company (ATL), a leading provider of aesthetic laser products, today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling the Company to manufacture and market its Angelite family of intense pulsed light skin therapy systems.

The Angelite Family of Intense Pulsed Light Systems (inclusive of the hand pieces used to deliver pulsed-light energy) will be widely used in the area of photothermolysis, photocoagulation and dermatology, especially for surgical, aesthetic and cosmetic applications in the treatment of acne, various benign pigmented lesions and hair removal, that require in.

Angelite Intense Pulsed Light System uses wavelengths ranging from 400 – 950 nm for the treatment of inflammatory acne, and wavelengths ranging from 560 – 1200 nm are indicated for the treatment of benign pigmented (epidermal and coetaneous) lesions including warts, scars and striae, and for the treatment of benign (coetaneous) vascular lesions including hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma,angiomas and spider angioma, poikiloderma of civatte, leg veins, facial veins and venous malformations. Wavelengths ranging from 700 – 1200 nm are indicated for the treatment of unwanted hair.

About Advanced Technology Laser Company (ATL)
Advanced Technology Laser Company (ATL) is a high-tech company and has been recognized to be a leading company in developing, manufacturing and distributing medical laser and optoelectronic systems. At ATL, a solid R&D team keeps strong connections with universities and research institutes all over the world, assuring it to produce cutting-edge products. Our goal is to continue bringing you the latest technologies and best quality products in industry of medical laser and optoelectronics at the affordable prices. For more information, please visit http://www.LaserATL.com.

Via EPR Network
More 
Healthcare press releases

Full-Mouth Rehabilitation and Bite Management of Severely Worn Dentition

Introduction
Creating a beautiful smile for a patient is extremely rewarding for the dentist as well as for the team, and this should never be taken for granted. We are blessed with the ability to change someone’s self esteem, confidence and, possibly, the course of their life.

The case presented here was featured on the cover of the Spring 2008 issue of The Journal of Cosmetic Dentistry. While it was quite challenging, I will never forget this case,, as it changed the life of a recovering bulimia patient. Eating disorders affect approximately seven million people in the United States. Although I have seen the effects of bulimia on the dentition previously, never have I witnessed it to this extent.

The patient was diagnosed with loss of vertical dimension as a direct result of bulimia and bruxism.

Patient History
The patient, a 30-year-old female, wanted to improve her smile and to address the constant fracturing of her teeth. Although it was difficult for her to discuss, she told me about her history of bulimia and that after a long struggle, she is now recovered. She was ready not only to change her smile, but also to see what could be done about her “collapsing” face, as she put it. She confessed that her unwillingness to smile was affecting her socially and that she always covered her mouth when she laughed (Fig 1).

Clinical Evaluation and Diagnosis
After performing a thorough clinical examination, I noted a severely worn dentition, widespread abfraction lesions, and multiple fractured teeth and restorations. The palatal surfaces of the maxillary anterior teeth were completely eroded and devoid of enamel, as is typically seen with bulimic patients (Figs 2 & 3). As expected, the patient’s teeth were very sensitive to temperature changes. Tooth #5 had been extracted due to a fractured root, and in its place was a successfully osseointegrated implant (Straumann USA; Andover, MA) that had been placed one year earlier. She had lost approximately 30% of the length of her central incisors due to attrition. Upon radiographic examination, no severe decay or pulpal pathology was evident. Periodontal probing depths were within normal limits.

The patient suffered f r o m many typical symptoms of temporomandibular disease (TMD), such as joint pain, severe headaches, tinnitus, and orofacial muscle pain with spasms.1These symptoms were not surprising, as craniomandibular dysfunction is often seen with loss of vertical dimension. She was also a severe bruxer and said this provided her with relief. Due to this vertical loss, the lower third of her face was collapsed and disproportionate. The patient was diagnosed with loss of vertical dimension as a direct result of bulimia and bruxism; this was accompanied by multiple fractured, eroded teeth, and worn restorations. Additionally, the patient had facial asymmetry and multiple TMD symptoms due to craniomandibular dysfunction.2

She tolerated the orthotic well and felt much better with it in place.

Treatment Plan
Initially this case was overwhelming, as there were so many factors necessary to achieve a successful treatment outcome. After mounting and studying the casts, it was obvious that the patient’s vertical dimension had to be increased to a proper, comfortable position, which has been called the physiologic neuromuscular position.3 Once this position was determined, an orthotic appliance would be worn to verify that this proposed position was in fact well tolerated and that the TMD symptoms had decreased significantly. During the orthotic therapy phase, this appliance would be worn for a minimum of three months (for a minimum of 22 hours a day), to determine whether it would help before any permanent alteration of the patient’s teeth.

During this time, her condition would be evaluated for elimination of symptoms, proper occlusion, improvement in facial symmetry, esthetics, and acceptable phonetics. If we had not seen improvements during the orthotic phase, the first thing we would have looked at was compliance. If it had been determined that the patient was not wearing the appliance as instructed, or if the therapy had had to be extended beyond three months (due to inconsistent symptoms or an unstable bite position), we would have used a fixed orthotic appliance, which would have been fabricated to the same vertical dimension as the removable orthotic.4

The goal, for any clinician, is to find a position in which the patient’s symptoms are eliminated, or at least decreased significantly. The facial and dental esthetics also must be greatly enhanced. Although there is more than one way to find this physiologic position, in this case I objectively measured muscle activity by using electromyography (EMG) instrumentation (Myotronics-Noromed; Kent WA). This enabled me to locate the correct resting position for the mandible where the muscles are at rest, as well as the correct opening and closing trajectory.5 During the course of orthotic phase therapy, which can last several months to a year, the patient returns to verify the bite and evaluate symptoms several times. Once it is determined that the patient is comfortable, facial esthetics are improved, and the EMG muscle activity is verified to be physiologic, then the restoration phase can begin.6,7

Treatment Discussion
The first step in this case was to determine how much to increase the patient’s vertical dimension. Once this position was determined, it was imperative to test and verify it; and, most importantly, to maintain it throughout the different phases of treatment. The treatment phases were as follows: Orthotic, preparation, temporization, and cementation.

Finding the Bite
To evaluate the state of the patient’s habitual bite position, we had to record and evaluate EMG readings of several muscle groups bilaterally (K7 instrumentation, Myotronics-Noromed). The muscle groups measured were the anterior and posterior temporalis muscles, the masseters, and the anterior digastrics. Electrodes were placed over these muscle groups and electromyographic recordings were made. High EMG readings represented a state of muscle hypertonicity and unrest. The goal was to find the occlusion where the muscles that control jaw position are in a relaxed state, and therefore are at their ideal resting length for optimal function and comfort.8,9

To find a more optimal bite position, a series of diagnostic tests were performed. These included electrosonography to record and analyze joint sounds, electromyography to record and analyze muscle activity, and computerized mandibular scanning (CMS) to track and analyze jaw movements. It was determined that the patient’s habitual occlusion was in a muscular state of hyperactivity when at rest and in light centric occlusion (Fig 4). In order to relax her muscles, which were in a chronic spasmodic state, ultra-low frequency transcutaneous electrical neural stimulation (TENS) was applied using a myomonitor (Myotronics). The myomonitor stimulates cranial nerves V, VII, and XI to relieve hypertonicity, restore normal blood flow, and wash away toxic wastes such as lactic acid. This restores the muscles temporarily to a relaxed and normal resting length (Fig 5). These muscles become “deprogrammed,” and, by measuring their pre- and post-relaxation status, we are provided with precise and objective comparative data.10,11 The details of all the tests performed during the three-hour diagnostic appointment are beyond the scope of this article.

The position at which this patient’s muscles were in their most relaxed state was captured by using a polyvinyl siloxane bite registration material (Regisil, Dentsply Caulk; Milford, DE). Impressions were then taken (Aquasil Ultra, Ivoclar Vivadent; Amherst, NY) and sent to the laboratory with the bite to fabricate a lower removable orthotic. Upon delivery of this appliance, I explained to the patient that it must be worn a minimum of 22 hours a day. Each follow-up visit always consisted of 45 minutes of TENS, followed by any necessary occlusal adjustments to the orthotic. The patient was seen at one-, two-, three-, four-, and sixweek intervals. She tolerated the orthotic well and felt much better with it in place; therefore, compliance was not an issue.12,13

Once it was determined that the bite was stable and that symptoms were significantly reduced, EMG recordings were taken again to verify that the muscles were not hypertonic in this new position. In this case the EMG readings were more than satisfactory, and the patient’s headaches and other symptoms were reduced significantly. Therefore, I had great confidence as to where to restore her occlusion.14 Her bite was opened 4 mm. The next phase of treatment was the restorative phase.

Bite Management
(Laboratory Phase) Much effort was spent determining the proper physiologic position for this patient, and much care had to be taken in managing and maintaining this position throughout the course of treatment. Prior to the preparation appointment, new impressions were taken and sent to the laboratory, along with the actual adjusted orthotic to mount the case. In addition, three measurements were provided so that the laboratory could verify that the case was properly mounted. These measurements were taken with a digital Boley gauge. The areas measured were where the most apical areas of tooth surface intersect with the gingiva between teeth #8 and #25, #14 and #19, and #3 and #30 (Figs 6 & 7). In this situation, the dentist and the laboratory must measure in the exact same three locations throughout the course of treatment, so as to ensure accuracy and precision in maintaining the new vertical (Figs 8 & 9).

Once the laboratory mounted the casts with the adjusted orthotic in place and the three measurements were verified, a bite stent (Sil-Tech, Ivoclar Vivadent) was made, to be utilized during the preparation appointment to ensure accuracy in maintaining the new vertical dimension. The appliance was then immediately returned to the patient so that she could continue to wear it. The laboratory also was provided with detailed instructions concerning the smile design, including widths and lengths of anterior teeth, shapes, and proportions.15

Because the patient’s maxillary anterior teeth were short, it was determined that crown lengthening was necessary to support the restorations. Therefore, the proposed amount of hard and soft tissue removal was relayed to the laboratory so that they could compensate for the change in measurement in this area. With this information in hand, they waxed up the 28 teeth in the new position, taking into consideration the hard and soft tissue reduc-tion in the anterior; and once again verified the three measurements (Fig 10). From this wax-up, they prepared a temporization stent made f r o m Sil-Tech putty and relined with a light-body wash material (Aquasil XLV, Dentsply Caulk). This would be used to fabricate the 28 temporaries after tooth preparation, with the same vertical dimension and occlusion as the orthotic.

Bite Management
(Preparation Phase) Prior to the preparation appointment, I ensured that I received everything necessary f r o m the laboratory. First, I verified that the waxed-up models were consistent with the three measurements I had provided to the laboratory, by measuring the teeth in the exact same three locations. Second, I verified that I was satisfied with the smile design and occlusion. As this was to be a lengthy appointment, the clinical team met and reviewed procedures.

After the patient was seated, I verified the bite stent that had been made on her unprepared, mounted models by placing it in her mouth and having her close down on it. I again measured the same three locations and verified that those measurements were the same as they were with the orthotic in place (Fig 11). I was confident that all of my numbers were accurate, so it was time to begin preparing the teeth.

It was imperative not to lose control of the bite at any time during the preparation.

After anesthetizing the patient, the first step was to perform the soft and hard tissue crown lengthening in the maxillary anterior region to improve the length of her short clinical crowns. To accomplish this, I used an Er,Cr:YSGG hard/soft tissue laser (Waterlase, Biolase Technologies; Irvine, CA) and at the same time performed a frenectomy between the maxillary central incisors. Using this laser provided a predictable result and gave me a clean field within which to work. I removed 1.2 mm of tissue and therefore changed the location of my uppermost point for measurement after the crown lengthening. I had to adjust my number for verification f r o m this point on, in this area only16 (Fig 12).

It was imperative not to lose control of the bite at any time during the preparation. To help in maintaining this vertical dimension, I used the bite stent provided by the laboratory to sequentially reline it while I prepared one quadrant at a time. Beginning with the upper right quadrant, I prepared ##3-8, while leaving #2 unprepared to provide extra stability while I relined the bite stent. To register the bite, I sat the patient upright and placed a small amount of fast-setting bite registration material (Regisil Rigid) in the bite stent, being careful not to overfill it and to reline only the prepared teeth. This was then placed in the mouth with the patient biting into it. While the stent was in her mouth, the same three locations were measured again, remembering that the anterior area had a new measurement. If the measurements had not matched those taken previously it would have been necessary to repeat the reline, as the patient might have been biting incorrectly or the bite stent might not have been seated over the teeth properly.

Once it was determined that the measurements were correct, the stent was removed, trimmed, and set aside for the next quadrant. The same procedure was repeated for the upper left quadrant, preparing ##9-14 and leaving tooth #15 unprepared. This quadrant was then relined the same way. After the measurements were verified, I prepared #2 and #15 (Fig 13). This procedure was repeated for the bottom right quadrant and then the bottom left. A final check of the measurements was made and the bite stent was set aside to send to the laboratory along with final impressions. For these, I used a PVS heavy-body material and an extra-low viscosity wash material (Aquasil Ultra-heavy and XLV). A symmetry bite was also taken, indicating to the laboratory the proper occlusal plane and midline. Photographs of the preparations, which showed the measurements with the final bite stent seated and with the symmetry bite in place, were provided for the laboratory.

Temporization
The provisional restorations were fabricated using the temporary stents made f r o m the wax-up. The stents were filled with temporary material (Luxatemp shade B1, Zenith/DMG; Englewood, NJ) and placed over the maxillary prepared teeth. After three minutes the stent was removed, as was a small amount of flash. This procedure was repeated for the bottom teeth. Once the provisionals were in place, all three measurements were once again verified; at this time we evaluated esthetics and occlusion. To properly maintain the health of the gingival tissue during the four-week provisional phase, the patient was given a sonic toothbrush (Sonicare, Philips Healthcare; Andover, MA), as well as instructions on how to use rubber tips to massage her tissue. A follow-up visit was scheduled for the next day to confirm that the occlusion was comfortable and that we were both satisfied with the smile design.

Laboratory Communication
Proper communication with the laboratory is crucial for a successful outcome in each and every case sent to our ceramist. In this case, it was important to send as much information as possible with regard to maintenance of the patient’s vertical dimension, as well as esthetics. Photographs showing all three measurements in the final bite stent, as well as in the provisionals, were sent to the laboratory. In addition, retracted frontal and lateral views of the preparations were provided, as well as a picture showing the prepared shade (Vita A3, Vident; Brea, CA).17 When the laboratory received the case, the first step was to verify the measurements after mounting the prepared models. This was accomplished by using the relined bite stent and verifying the accuracy of the vertical dimension in the same three locations.

For the smile design, we decided on a “soft” look with square oval central incisors and slightly rounded laterals and canines, with the lateral incisors 0.5 mm shorter than the centrals. The requested width of the central incisors was 8.25 mm and the length was 10.75 mm. The lateral incisors were approximately 10.25 mm long. Golden proportion rules and smile design principles were adhered to, which provided the patient with a very soft and esthetically pleasing smile. Our final shade choice was OM2 body with a cervical blend to OM3 (Vita 3D Master shade guide), with the canines blending f r o m OM2 to 1M1 cervically. We selected Authentic pressable ceramic (Jensen Indus-tries; North Haven, CT) for all anterior teeth and bicuspids, using an OP1+ ingot with cutback technique and adding intense opaque modifiers to increase vitality and a natural appearance (Fig 14).18All of the molars were restored with Noritake CZR pressable ceramic (Zahn Dental, Henry Schein; Melville, NY) over zirconia copings.19 The #5 implant was restored with a custom abutment with Creation porcelain (Jensen Industries). Prior to the fabrication of the restorations, the models were mounted using the preparation bite stent, and all the measurements were verified by the laboratory (Figs 15-18).

Cementation
After we received the case f r o m the laboratory, I checked the restorations on the models for proper margins and contacts, and to ensure that the smile design had been followed. Once all the restorations were mounted on the models, the three areas were measured to verify that the laboratory maintained the vertical dimension. Once the patient was anesthetized, the provisional restorations were removed. The prepared teeth were cleaned with pumice, followed by hydrogen peroxide and chlorhexidine (Consepsis, Ultradent; South Jordan, UT). Each restoration was tried on with water and inspected individually. Contacts and margins were examined, as was the overall smile design.

Once we were satisfied with restorations, they were cleaned with 37% phosphoric acid, rinsed, dried, and set aside. The molars were cemented first using Multilink (Ivoclar Vivadent), a self-etching universal resin cement, with the inside of the restorations coated with the metal/zirconia primer (Ivoclar Vivadent). Then all of the remaining upper teeth except #5 were etched with 37% phosphoric acid and rinsed, after which a wetting agent was applied (Super Seal, Phoenix Dental; Fenton, MI).20 Then the bonding agent (Excite, Ivoclar Vivadent) was placed on the teeth according to manufacturer’s directions and light-cured. The restorations, which had previously been etched with hydrofluoric acid, were coated with Silane primer (Kerr; Orange, CA). The luting resin used for cementation was Variolink Veneer +2 (Ivoclar Vivadent). All of the restorations were placed simultaneously and spot-cured. The excess was then removed, followed by the final light-cure. Tooth #5 was cemented with implant cement (Premier Dental; Plymouth Meeting, PA).21 The same technique used on the maxillary teeth was applied to the lowers. Once all teeth were cemented, the three measurements were once again verified to confirm maintenance of the vertical dimension (Fig 19). The patient returned for follow-up appointments to make sure her bite was stable and that she remained symptom-free.

Conclusion and Discussion
This patient’s case involved many of the challenges we face daily in our practices. Just a few years ago, however, I would not have known in which direction to take her treatment. Perhaps I simply would have provided her with a bruxism appliance, while “patching up” some of her fractured restorations and attempting to improve her smile by restoring some of her anterior teeth with direct resins. These would have failed repeatedly, causing us both much frustration.

I conducted a series of diagnostic tests using computerized instrumentation, which provided me with objective data that I was able to use in my treatment planning.

The key point is that this patient initially exhibited severe occlusal disharmony and craniomandibular dysfunction. This can be the case in many of our patients, and much effort should be spent in proper diagnosis and treatment planning.22 I did not prepare 28 teeth in one visit and deliver them a few weeks later. Instead, I conducted a series of diagnostic tests using computerized instrumentation, which provided me with objective data that I was able to use in my treatment planning. Not until the patient’s new vertical dimension position was tested for several months did I dare touch a single tooth with a handpiece. Once I did, however, it was with great confidence, because I knew in which direction I was headed (Figs 20 & 21).

It is well accepted that there is more than one philosophy or method that can be utilized to arrive at a physiologic bite position. A discussion of these different philosophies— whether centric relation, centric occlusion, or neuromuscular—is beyond the scope of this article.23 However, as responsible clinicians, we should study the different treatment modalities available to our profession before making a decision as to which one suits us. Whichever method you apply in your practice, the most important factor is that it must be in your patients’ best interests.24 Before proceeding to final restorations, it is imperative to establish a comfortable, stable bite derived f r o m verifiable, objective clinical data (Figs 22-29).

Acknowledgments
The author thanks Duckee Lee, CDT (Protech Dental Studio, Sterling, VA), for his passion, talent, and technical excellence in creating the beautiful restorations in this case. A debt of gratitude also goes to the American Academy of Cosmetic Dentistry for 13 years of excellent continuing education, camaraderie, and a remarkable credentialing program, in which he learned during his Accreditation journey that, “your hand can only perform what your eyes have been trained to see and comprehend”; and to the Las Vegas Institute for Advanced Dental Studies for its dedication to postgraduate education. Finally, thanks, appreciation, and best wishes goto Erica, the patient in this case, for her patience, kind spirit, and courage.

References

1. Okeson JP. Management of Temporomandibular Disorders and Occlusion (3rd ed.). St. Louis, MO: Mosby; 1985.

2. Coy RE, Flocken JE, Adib F. Musculoskeletal etiology and therapy of craniomandibular pain and dysfunction. Cranio Clin Int 1(2):163-173, 1991.

3. Jankelson RR. Neuromuscular Dental Diagnosis and Treatment. Volume 1 (2nd ed.). Tokyo: Ishiyaku EuroAmerica; 2005.

4. Naeije M, Hansson TL. Short-term effect of the stabilization appliance on masticatory muscle activity in myogenous craniomandibular disorder patients. J Craniomand Disord Facial Oral Pain 5:245-250, 1991.

5. Ormianer Z, Gross M. A 2-year follow-up of mandibular posture following an increase in occlusal vertical dimension beyond the clinical rest position with fixed restorations. J Oral Rehab 11:877-883, 1998.

6. Liu ZJ, Yamagata K, Ito G. Electromyographic examination of jaw muscles in relation to symptoms and occlusion of patients with TMJ disorders. J Oral Rehab 26(1):33-47, 1999.

7. Neill DJ, Howell P. Computerized kinesiography in the study of mastication in dentate subjects. J Prosthet Dent 55(5):629-638, 1986.

8. Mongini F, Tepia-Valenta G, Conserva E. Habitual mastication in dysfunction: A computer-based analysis. J Prosthet Dent 1:484-494, 1989.

9. Jankelson B. Three dimensional orthodontic diagnosis and treatment: a neuromuscular approach. J Clin Orthod 18(9):627-636, 1984.

10. Ow RK, Carlsson GE, Jemt T. Craniomandibular disorders and masticatory mandibular movements. J Craniomand Disord Facial Oral Pain 2(2):96-100, 1988.

11. George J, Boone M. A clinical study of rest position using the kinesiograph and myomonitor. J Prosthet Dent 41(4):456-462, 1999.

12. Konchak P, Thomas N, Lanigan D, Devon R. Freeway space using mandibular kinesiography and EMG before and after TENS. Angle Orthod 58(4):343-350, 1988.

13. Balciunas BA, Stahling LM, Parente FJ. Quantitative electromyographic response to therapy for myo-oral facial pain: A pilot study. J Prosthet Dent 58:366-369, 1987.

14. Isberg A, Widmalm S, Ivarsson R. Clinical, radiographic, and electromyographic study of patients with internal derangement of the temporomandibular joint. Am J Ortho 88(6)453-460, 1985.

15. Griffin JD. How to build a great relationship with the laboratory technician: Simplified and effective laboratory communications. Contemp Esthet 10(7):26-34, 2006.

16. Colonna M. Crown and veneer preparations using the Er,Cr:YSGG Waterlase hard and soft tissue laser. Contemp Esthet Rest Pract 10:80-86, 2002. 17. Bengel W. Mastering Dental Photography Hanover Park, IL: Quintessence Pub.;2002.

18. Magne P, Belser U. Bonded Porcelain Restorations in the Anterior Dentition: A Biomimetic Approach. Hanover Park, IL: Quintessence Pub.; 2002.

19. Ludwig K. Studies on the ultimate strength of all-ceramic crowns. Dent Laboratory 39:647-651, 1991.

20. Kanca J. Improving bond strength through acid etching of dentin and bonding to wet dentin surfaces. JADA 123:35-44, 1992.

21. Garg AK. Practical Implant Dentistry (1st ed.). Dallas, TX: Taylor Publishing; 2007.

22. Tingey EM, Buschang PH, Throckmorton GS. Mandibular rest position: A reliable position influenced by head support and body posture. Am J Orthod Dentofac Orthop 120(6):614-622, 2001.

23. Pully ML, Carr S. Solving the pain puzzle: Myofascial pain dysfunction (3rd ed.). Albuquerque, NM: TMData Resources; 1997. 24. Shankland WE . Temporomandibular disorders: Standard treatment options. Gen Dent 52(4):349-355, 2004.

 

Via EPR Network
More Healthcare press releases

Jenken Biosciences Granted Key Patent for Compounds To Treat Chronic Liver and Kidney Diseases

Jenken Biosciences, Inc., an emerging specialty pharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent on Jenken’s compounds for the treatment of diseases associated with kidney diseases and chronic liver diseases, such as hepatitis and fatty liver disease.

Jenken’s patented compounds are developed by “repurposing” FDA-approved off-patent drugs for new, first-in-class therapeutic uses.

The patent, US 7501433, “Opioid and opioid-like compounds and uses thereof,” with an anticipated term through 2022, will provide broad protection for the Company’s repurposed drugs’ new indications targeted at treating organ damage associated with chronic liver or kidney diseases.

The Company’s leading drug candidate has been approved by the FDA for a Phase II clinical study targeted at treating liver damage in Hepatitis patients. The endpoint of the study will be to restore normal liver function by reducing inflammation in Hepatitis C patients who do not respond to current interferon/anti-viral therapies.

Jenken’s second clinical candidate has exhibited efficacy in preclinical trials as an anti-fibrotic for treating fatty liver disease.

“The validation by the USPTO of the potential utility of our compounds is a significant step in making totally new therapeutic options available to the millions of patients around the world who suffer from chronic liver diseases, such as hepatic fibrosis, steatohepatitis (NASH) or fatty liver disease,” said Barry Buzogany, Jenken’s President and CEO.

“In the U.S. alone, approximately 25 million people are afflicted with some form of chronic liver disorder,” Buzogany explained. “Of these, there are about four million people infected with the Hepatitis C virus and another 12 million with fatty liver disease. Currently there are no therapies available to treat liver damage associated with either hepatitis or with fatty liver disease.”

According to Dr. Edwin Wu, Jenken’s Founder and Chief Scientific Officer, “Jenken’s proprietary technology for cytokine modulation, a specific therapy for diseases associated with chronic inflammation, offers the potential to restore normal liver or kidney function regardless of the cause of the damage or disease.”

Via EPR Network
More 
Healthcare press releases

Lloydspharmacy Has Become The First Major Healthcare Brand To Offer Women The ‘Morning After Pill’ In Advance Of Need

The online service is aimed at women who are concerned that they may not be able to access the treatment, also known as Emergency Hormonal Contraception (EHC), when they need it, such as whilst travelling or during weekends and bank holidays. The new service is also ideal for women who may be anxious about visiting a pharmacy or their local GP for this type of medication.

The service is available through Lloydspharmacy as part of an online partnership between the pharmacy and the Healthcare Commission regulated online health expert DrThom.

“With the emergency pill, time is of the essence,” said Clare Kerr, Head of Clinical Services at Lloydspharmacy, “The treatment is up to 95 per cent effective when taken 24 hours after sex but that reduces to 85 per cent in the following 24 hours and dips to 58 per cent in the next 24 hours.”

“Most women know that the morning after pill can be taken up to three days after sex,” she said, “but our pharmacists tell us that many women are unaware of the fact that effectiveness reduces during that period.”

The Lloydspharmacy online service is explicitly not aimed at women who have just had unprotected sex. They are advised to visit their pharmacist or GP straight away. There is a 72 hour delay in despatching treatments to discourage women from using the service in this way.

The online pharmacy service will not knowingly be made available to patients under the age of 18 and treatments will only be despatched to the person whose name is on the credit or debit card used to make the payment online.

Women must fill in a comprehensive online medical questionnaire which is reviewed by DrThom before treatment can be prescribed and dispensed by post. Women are able to access advice from a DrThom GP using their confidential online patient record.

“Unplanned pregnancy is an issue that can affect all sexually active women, including those in long term relationships,” said Clare Kerr. According to the British Pregnancy Advisory Service, one in three women in the UK will have an abortion by the time they are 45 and about 30 per cent of all pregnancies are unplanned.

“We hope that our new service will go some way to reducing the number of unplanned pregnancies and will help alleviate some of the anxiety women feel after they’ve had unprotected sex or a condom has split,” Claire concluded.

 

About Lloydspharmacy
Lloydspharmacy has around 1700 pharmacies across the UK. These are based predominantly in community and health centre locations. The company employs over 16,000 staff and dispenses over 145 million prescription items annually.

Lloydspharmacy is the trading name of Lloydspharmacy Ltd, a wholly owned subsidiary of Celesio AG based in Stuttgart. Celesio is the leading pharmaceutical distribution company in Europe and is represented in 16 countries. With its three divisions, Celesio Wholesale, Celesio Pharmacies and Celesio Solutions, the group covers the entire scope of pharmaceutical trade and pharmaceutical-related services.

Via EPR Network
More
Healthcare press releases

Tummy Tuck And Liposuction, Before And After Photos

Tummy tuck and liposuction, before and after photos demonstrate why this combined surgery is becoming ever more popular. At £2846, it has become more affordable for many men and women to have the combined procedure to their tummy region.

Tummy tuck surgery at an affordable price, provided by Beautiful Beings.

Abdominal cosmetic surgery, commonly known as a tummy tuck offers a solution by flattening the slack skin and tightening the muscles of the relaxed abdominal wall, which frequently occurs after pregnancy or a distinct weight loss.

If needed, excess subcutaneous fatty tissue can be removed as well. The appearance and functional results of the tummy tuck are substantial, although scars are inevitable in order to remove excessive skin from the tummy during a tummy tuck. It leaves a permanent scar after. However, it will fade after time and its quality differs per individual. A tummy tuck is not only an aesthetic cosmetic surgery procedure but it provides a solution to functional deficiencies of the abdominal wall, i.e. inferior rectus muscle diastases. A tummy tuck not only brings about a better appearance and function, but it also stops the slackening process of the abdominal wall.

Via EPR Network
More 
Healthcare press releases

Gastric Band – £3980, inlcuding 3 x-ray assited refills

The Gastric Band surgery will be carried out in a specialist state hospital in Prague. www.beautifulbeings.co.uk

Gastric Band surgery is not an instant solution to weight loss. Having a gastric band fitted will assist in decreasing overall daily food intake and can help you achieve a sustainable weight.

The Gastric band works by causing a feeling of fullness when eating and will enable you to reduce your daily intake of food and calories. The gastric band will make you eat less, it will reduce the sensation of hunger and will progressively aide weight loss.

This is achieved by placing the band around the uppermost part of the stomach, dividing it into two sections, with a small opening between sections which allows food to pass through. The section above the band forms a small pouch that fills with food quickly.

Having the gastric band fitted will lead to a healthier lifestyle and lower the risks of obesity related illnesses However changing your eating habits is an important part of the gastric band surgery process. The gastric band will help you to achieve substantial weight loss and reduce the risk of obesity related illnesses. To achieve the maximum benefits from having the gastric banding, post-operative discipline is an important part of the process.

You will need to go on a diet immediately after the gastric band surgery. You will obtain a detailed dietary plan with essential and important advice from your specialists. After the gastric band surgery you can consult the plan with a dietologist recommended by your doctor.

Generally it means that following the gastric banding you will only be able to consume liquid food within the first four weeks such as soup, tea, coffee, unsweetened drinks, fruit and vegetable fruits, yoghurts etc. You will need to reduce the amount of fluids consumed and not eat or drink large amounts at once.

The following two weeks you will be able to eat small portions of mushy, mixed food.

Next the diet will be replaced with common food. Please consult your doctor for more detailed information.

These slow changes of eating habits are important for your recovery. During this process the gastric band will be, thanks to body tissue, firmly placed on the appropriate part of your stomach. Consuming large portions or frequent consumption of solid food increases the risk of dislocating (moving) the gastric band out of its position or the possibility of gradual upper stomach pocket stretching. The consequence might be reduced weight loss and in some cases necessity for re-operation.

Following the gastric banding you might find some food hard to eat. You will need to chew your food more carefully than before the gastric band surgery. Keep in mind that even after the gastric banding there is no quick solution to reduce your weight. The results depend upon your ability to respect recommendations concerning your diet and exercise routine.

Via EPR Network
More 
Healthcare press releases

Catalent Analytical Team Member to be Published in Journal of Pharmaceutical Research

Catalent Pharma Solutions, a worldwide leading provider of advanced technologies for pharmaceutical, biotechnology and consumer health companies, will be featured in the upcoming April edition of Journal of Pharmaceutical Research. Stephen P. Mayock, a member of Catalent’s analytical team, was a major contributor to the article that conveys the present challenges and future relevance of the science of USP 1 and 2 dissolution.

The article begins with the scientific origins of the dissolution test and discusses the roles of dissolution in product development, consistent batch manufacture and stability testing. It also reviews the ultimate role of dissolution testing where the end results correlate to in vivo results. Other topics that are covered in the article include the mechanical calibration versus performance testing, variability and hydrodynamics of USP Apparatus 1 and 2 and new initiatives in the industry such as quality by design, process analytical technology and design of experiment.

Mayock is the senior manager in Catalent’s Stability and Analytical Services Group. Catalent’s analytical team is part of its Respiratory, Analytical and Biotechnology group, with sites in the Research Triangle Park, N.C., San Diego C.A., and Middleton, W.I. Mayock joins fellow authors Vivian Gray, Gregg Kelly, Min Xia, Chris Butler and Saji Thomas. The article has been available online to subscribers since Jan. 25, 2009, and the print version will be available in the April edition.

About the Journal of Pharmaceutical Research
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers that describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published.

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at more than 30 facilities worldwide and generates more than $1.8 billion of annual revenue. For more information, visit www.catalent.com.

Via EPR Network
More
Healthcare press releases

Barack Obama Signs Proclamation Save Your Vision Week 2009 – BiCOM with Glaucoma Eye Test Diaton is Preparing to Help

Barack Obama, President of the United States of America proclaims March 1 through March 7, 2009, as Save Your Vision Week. BiCOM Inc home of Glaucoma Eye Test Diaton – non-contact Glaucoma Eye Test through the Eyelid is prepared to assist with vision screenings. Roman Iospa, CEO of BiCOM comments on Presidents support of glaucoma screenings. Early diagnosis and timely treatment are critical to minimize vision loss from eye diseases.

Proclamation by the president of the United Stated of America addresses the important issue of Blindness and visual impairment that affects millions of Americans. Early diagnosis and timely treatment are critical to minimize vision loss from eye diseases. During Save Your Vision Week – Barack Obama encourages all Americans to take action to prevent their vision loss.

BiCOM Inc. home of Glaucoma Eye Test Diaton Tonometer (IOP through the Eyelid), has been a long supporter of preventive glaucoma screenings. At a recent free glaucoma screening event where BiCOM in conjunction with SAVE Program (Sight for a Vision Exchange) and The Congressional Glaucoma Caucus Foundation conducted at New York City Children’s Services in honor of African American Heritage Celebration has revealed many with elevated intraocular pressure (IOP) a major risk factor for glaucoma. Patients were referred to an ophthalmologist Dr. Lynnette P. Williams-Young a glaucoma specialist for further evaluation.

Unfortunately, most people have limited knowledge of blinding eye disorders. Based on National Eye Institute 2005 study, only eight percent of respondents knew that glaucoma, a condition that can damage the optic nerve and cause vision loss and blindness, strikes without early warning. Similarly, glaucoma also begins as a silent vision threat; as per Prevent Blindness America, it is estimated that of those Americans that have glaucoma, only half know they have it. It is estimated that 60 million Americans are at risk for developing glaucoma.

Everyone should be screened, especially with availability of new non-invasive (over the eyelid) glaucoma screening technology aka “Glaucoma Eye Test” Diaton tonometer available to optometrists, ophthalmologists and general physicians, enabling doctors to quickly and painlessly screen individuals at risk.

Several demographic groups are at higher risk for visual impairment, including teenagers, diabetics, Hispanics, African Americans, and the economically disadvantaged. Older Americans are more susceptible to eye conditions such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Children need regular vision screenings because vision disorders left untreated during childhood can lead to permanent visual impairment during adulthood.

President Obama stated, “Eye disease knows no bounds, and every American should take steps to protect his or her eyesight.”

To remind Americans about the importance of safeguarding their eyesight, the Congress, by joint resolution approved December 30, 1963, as amended (77 Stat. 629; 36 U.S.C. 138), has authorized and requested the President to proclaim the first week in March of each year as “Save Your Vision Week.”

“I’m pleased to see that President Barack Obama, with only weeks in the office is addressing an important issue of blindness, its early detection and timely treatment. My whole team at BiCOM Inc., and our partners are ready to continue our efforts and act on a larger scale by reaching out to many more people through awareness, training, glaucoma screening events and making “Glaucoma Eye Test” Diaton tonometer available to all that are willing to participate,“ said Roman Iospa, CEO of BiCOM Inc.

From the website of the White House:http://www.whitehouse.gov/the_press_office/Save-Your-Vision-Week-2009/

“NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, do hereby proclaim March 1 through March 7, 2009, as Save Your Vision Week. During this time, I invite eye care professionals, teachers, members of the media, and all organizations dedicated to preserving eyesight to join in activities that will raise awareness of vision diseases and disorders.”

About BiCOM Inc:
BiCOM, with its 15 years of tradition and global clientele, has proven to be the enterprise of the highest level of professionalism, integrity and financial solvency. A unique team of engineers, medical, legal and business experts makes BiCOM Inc. the right place for global talent to find support and guidance. BiCOM Inc. sees its mission in bringing to market innovative products developed and manufactured worldwide. More about Diaton tonometer:
TonometerDiaton.com

BiCOM represents and supports Glaucoma Eye Test aka Diaton tonometers in over 50 countries and growing. BiCOM conducts Free Glaucoma Screening Events throughout the Globe.
BiCOM-Ophthalmic.com

Via EPR Network
More
Healthcare press releases

Lexington Medical Center and Providence Hospitals Reach Significant Agreement

After several months of discussions, Lexington Medical Center and Providence Hospitals are pleased to announce the terms of an agreement that advances both of their efforts to improve health care delivery in the Midlands of South Carolina. Specifically, Providence Hospitals will support Lexington Medical Center’s efforts to secure an open heart surgery program and Lexington Medical Center will drop its objections to a proposed expansion at Providence Hospitals Northeast.

Under the terms of this agreement, Providence Hospitals will support Lexington Medical Center in seeking regulatory approval through a joint Certificate of Need (CON) application. Within the application, Lexington Medical Center will request approval for one open heart surgery suite and the authority to perform open heart surgery and therapeutic cardiac catheterizations. If approved by the South Carolina Department of Health and Environmental Control (DHEC), Providence Hospitals will de-license one of its open heart surgery suites, allowing Lexington Medical Center to add a suite, in keeping with the 2008-2009 State Health Plan.

Lexington Medical Center has dismissed its lawsuit which opposes Providence Hospitals’ plans to expand and improve its existing Northeast facility. Additionally, Lexington Medical Center, upon licensing of the new heart program, would provide $15 million over a three-year period to Providence Hospitals in consideration of de-licensing one open heart surgery suite. Those funds will allow Providence Hospitals to reinvest in technologies and equipment for other service lines.

Lexington Medical Center’s unique situation as the only hospital located within Lexington County, with one of the state’s busiest emergency departments and a busy diagnostic catheterization lab, supports the need for a full service open heart surgery program to perform open heart surgery and therapeutic catheterizations. This agreement will allow Lexington to obtain such a program for the citizens of Lexington County.

Providence Hospitals believes that this joint CON application will not create new capacity in the open heart market, since no new open heart surgery rooms are being added to the service area. In addition, Providence believes that collaborating with LMC on the delivery of health care services and preserving the integrity of the health planning process is in the long term best interests of the Midlands community. While each of the hospitals will continue to be strong health care competitors, they may now also be able to explore additional strategies that would serve to improve patient care.

Providence Hospitals President and CEO George Zara noted the impact of working collaboratively in coming to a resolution on the issue. “In keeping with our faith-based mission, it is incumbent that we move past these conflicts to focus on our common goals of providing quality patient care.”

Mike Biediger, Lexington Medical Center’s president and CEO commented on the joint agreement, “For years, it has been our priority to make cardiovascular care more accessible to the people of Lexington County. We are now one step closer to achieving that goal. We fully expect that this agreement will allow us to address acute cardiac events in a more timely fashion, ultimately saving more lives.”

According to Thad Westbrook, chairman of Lexington Medical Center’s board of directors, “This agreement has been a long time coming and is an important milestone for citizens of Lexington County and the Midlands. The need for a full service open heart program for the people of Lexington County has never been greater, and we now see that our dreams may soon be realized thanks to this agreement with our colleagues at Providence Hospitals.”

Providence Hospitals’ board chairman Michael Kapp is optimistic about the understanding the two hospitals have reached. “I firmly believe that this marks a turning point in the relationship between Providence Hospitals and Lexington Medical Center. We have put aside our differences in order to pursue initiatives that will advance the delivery of quality health care for the people of the Midlands.”

Both Providence Hospitals and Lexington Medical Center appreciate the volunteer assistance of Mr. Frank Mood, senior vice president & general counsel for SCANA, during the mediation process.

About Lexington Medical Center

Lexington Medical Center, in West Columbia, S.C., anchors a county-wide health care network that includes six community medical centers throughout Lexington County and employs a staff of 5,100 health care professionals. The network also includes the largest extended care facility in the state, an occupational health center and physician practices. At its heart is the 384-bed state-of-the-art Lexington Medical Center, with a reputation for the highest quality care. Lexington Medical Center was voted one of the “Best Places to Work” by the South Carolina Chamber of Commerce, “Best Hospital” by readers of The State for nine years in a row, “Best Hospital” by readers of the Free Times and “Best Place to Have a Baby” by readers of Palmetto Parent. Visit http://www.lexmed.com or http://www.lexmed.tv.

About Providence Hospitals

Sponsored by the Sisters of Charity Health System, Providence Hospitals was founded by the Sisters of Charity in 1938 and is known statewide for its compassionate care. This non-profit organization is licensed for 304 beds at its downtown and Northeast facilities and employs more than 1,900 caring individuals. Providence Heart & Vascular Institute is recognized nationally as a referral center for the prevention, diagnosis and treatment of cardiovascular disease with several national rankings for quality outcomes including the Society for Thoracic Surgeons and the American Heart Association’s Get with the Guidelines Coronary Artery Disease program. Blue Cross and Blue Shield of South Carolina recently designated Providence Heart & Vascular Institute as a Blue Distinction Center for Cardiac Care, signifying Providence’s commitment to quality care, resulting in better overall outcomes for cardiac patients. Learn more at http://www.providencehospitals.com.

Via EPR Network
More Healthcare press releases

The launch of the health site OmegaLifeLine.com boosts about all the health benefits of omega fatty acids and essential oils.

With consumer trepidation, it is great to see a site so dedicated to exploring the real health benefits of essential fatty acids. History tells us that during a weakening economy many people will suffer from poor eating habits as their buying patterns change.

Families will choose more budget conscious meals which may mean that they will save money in the short run, however if we take a step back and look at the long term picture it could equate to a more significant loss in the future.

As individuals health worsens (the culprit being a poor diet), society can expect to see a greater strain on an already taxed medical system. These individuals put themselves and their families at risk of more serious ailments. Diseases which could drastically reduce or end a families income.

Education is power and Omega Life Line is poised to educate men, women and teens about the necessity of consuming ‘healthy fats’. The modern diet is extremely unbalanced in the ratio of omega 3’s to omega 6’s. And that is a very dangerous and avoidable position for any person to be in.

Creator of the site Samantha Criddle explains, “everyday people are looking for miracle solutions to cure all their problems and sometimes it’s simpler than what they expected. The health benefits of omega oils are tough to ignore”.

What many people don’ t realize is that the body cannot manufacture the essential fatty acids that it requires to maintain proper body health and function. And that’s where people get into trouble. In understanding where to source healthy, nutrient rich omega oils, people can empower themselves and realize a healthier lifestyle.

For more information on omega oils we invite you to visit www.omegalifeline.com.

Via EPR Network
More Healthcare press releases

If you have been wondering about how it would feel to undertake drug rehab, then wonder no more

Drug treatment professionals are waiting at Sunset Malibu, a wonderful addiction treatment center above the Pacific, in Malibu California. Before beginning treatment a guest has to understand what drug addiction actually is and what drug rehab will involve. There must be a commitment on the part of the guest to undertake the treatment and have the desire to do so.

About fifteen million people in the U.S. have a form of addiction and it can run to quite of lot of things – such as drugs, alcohol, depression and even food. Addiction is not a choice so neither is getting help. Possibly the thought is daunting. A person can even get settled and comfortable, in a way, into an unhealthy and potentially deadly lifestyle. Why should you change, you may ask yourself, well, you can die, that’s why. And I think that in most people’s opinion, being alive is better than not being at all. When you are under the fog of addiction, things may seem unreal. Well, in a way, they are. This is not a normal way of living, therefore, they are abnormal. Only you can take the first step.

Deciding to get better and entering a drug rehab program is up to you. No one chooses to become addicted. You don’t wake up one day and tell yourself – “Oh, I’d love to live life like the sludge at the bottom of a swimming pool”. But you can, fairly easily, consider entering an addiction program. And if you make a wise choice and enter a program with a highly qualified set of professionals and stay at a wonderful place with innovative and gentle treatment, then you may find yourself, quite soon, swimming towards the sunlight sparkling at the top of a now clean and bright pool. No more bottom dwelling for you.

One of the best drug treatment centers, Sunset Malibu, has luxurious accommodations, more like a spa retreat, than anything else. As treatment centers are a place of hope, not despair, this can only help you on the path upwards towards recovery. You have to feel, and get involved, with the healing of your body and life. Trained professionals will help guide you. How much better is it not to try and go it alone? How much better to have caring people with an individualized and innovative program bring you upwards toward a new and renewed life.

You get a lot of aftercare and a support network from Sunset Malibu. People may look at you differently after a stay here. If you feel better on the inside, you will absolutely look better on the outside. Your mind will be in great shape, too. Think of all the things lost to you while you were addicted: Respect from your friends and family; love and creativity; hope and joy. Then think of all the things to be regained, and gained: They are the same things, and then some.

Millions of people in the U.S. are under the oppression of drug addiction. They are ordinary human beings just like you. Although there should be no stigma attached to an addiction disease, there often is. People say to themselves: “Oh – this person should just want to stop and then they can. It only takes willpower.” Well, that’s wrong. It takes a lot of courage and the ability to seek help. It takes one phone call to Sunset Malibu to get you started. And remember, their approach is gentle and innovative and holistic. Don’t be afraid of taking that crucial first step.

Do put your foot on the first flagstone of the path leading upwards, and give Sunset Malibu a call today. Their genuine caring and professional attitude can, and will, only help you. When you have a wonderful center like this facility is, and caring professionals to help you in gentle ways, who wouldn’t want to helped out of the darkness.

About Sunset Malibu: Professional staff will guide you to health at this rehab and addiction treatment center.

Via EPR Network
More
Healthcare press releases

Find an Unlikely Friend through a Premier Drug Rehab Center

Drug rehab center can be one of the scariest moments in a person’s life. The fear of not knowing what will be found on the other side of that door is crippling. Match this with the fear of what a new life will have to offer when the first steps are once again taken outside that same door. Only this time, the addict is re-entering society as a sober person. This scenario is what keeps many from seeking treatment in the first place.

Addiction to drugs and alcohol does not paint a pretty picture of life. There are loved ones scarred by the damage of an addict who will stop at nothing to get that next fix. Jobs are lost because a boss just can not tolerate one more late morning or missed day of work for what is long perceived to not be ‘illness’ related. It is at these moments that addicts begin to feel the emptiness. This emptiness drives the addict to find love and acceptance somewhere in some place.

It does not matter if that other place or time is a bottle or a needle being injected into the arm. All an addict knows is that place of acceptance and non judgment has finally been found. If this sounds like you do not fear there is help waiting just around the corner. Make a new friend and gain a fresh rehabilitated start to life at Cliffside Malibu.

Make no mistake the alcohol rehabilitation you will undergo here is not going to be easy. When times are tough you can not phone in a replacement or have a Hollywood ‘stand in’ go through the treatment steps in your place. This is your addiction and only you can make yourself better. But you do not have to do that alone. The personnel and staff at Cliffside Malibu will be there with you every step of the way. Your drug addiction more than likely entails a painful drug detoxification process. Even then you will not find yourself alone. Your new friends will be right beside you helping you every step of the way.

You may think that you do not deserve treatment. You make think that no one cares whether or not you even receive treatment in the first place. This could not be further from the truth with Cliffside Malibu. To the staff here you are more than just a patient number on a page or a dollar amount in the bank account. You are a living, breathing human being who made a few wrong turns in life. Let the staff at this premier drug rehab center help you pick yourself up, dust yourself off and get back to an addiction free life that you deserve.

You are fully aware of the fact that there have been some mistakes made along your path in life. No one needs to hold this over you in judgment or remind you of it on a daily basis. The staff at Cliffside Malibu is not there to humiliate or demean you. That would critically impair your road to recovery. Instead you will be provided with treatment options that empower you as a person. You will be reminded of the value you have in life and it is something that you will discover all on your own. This is the valued difference that sets Cliffside Malibu apart from others in the rehabilitation industry.

Flip through the yellow pages of the phone book or jump online for a quick Google search and you will soon find how many rehabilitation centers are available. No two centers are alike. It is imperative that you find one that suites the needs of your addiction. Select a rehab center that will go the extra mile in making sure your life outside the center is just as successful as your life inside the center. Cliffside Malibu can be that place for you.

About Cliffside Malibu:
Cliffside Malibu offers treatment program approaches based on individual need rather than a mass group approach. All treatments are tailored to each addict and include equine therapy, acupuncture and yoga. The rehabilitation center offers treatment for drugs, alcohol, eating disorders, depression and anxiety among others.

Via EPR Network
More 
Healthcare press releases

The Wohrle Dental Implant Clinic and Dr. Peter Wohrle are now able to offer patients Same Day Dental Implants at their Newport Beach California Dental Implants Clinic

BACKGROUND: About 22 million people in the United States have dentures or no teeth at all. Dental implants can offer a welcome alternative for those who want to regain their smile. The first modern dental implants hit the scene in the 1950s, and they’ve improved quite a bit over the years. Dental implants provide a base for replacement teeth that look and function like natural teeth. The implants are tiny titanium posts that are surgically placed into the jawbone where teeth are missing. The bone grows to the titanium, creating a strong foundation for artificial teeth.

According to the American Dental Association, the number of implants placed by dentists increased 49 percent between 1995 and 1999.

STANDARD IMPLANTS: Typically, dental implants are done in two surgical procedures. The dentist will have to refract (peel back) the gum tissue to see just where the implants will go to avoid sensitive nerves. When the proper placement is decided, the dentist will then place the implants into the jawbone. For the first three to six months following that surgery, the implants, which are just below the surface of the gums, bond with the jawbone. While the implants are bonding with the jawbone, new replacement teeth are made by the dentist. When the implants are fully bonded with the jawbone (again, a process that takes up to six months), the dentist is ready to fit the new teeth. The second procedure you undergo includes uncovering the implants and attaching the posts that act as anchors for the artificial teeth. The teeth are then attached to those posts. The entire process takes up to nine months to complete.

NOW, FASTER, EASIER IMPLANTS: Now, dentists are offering an innovative way to give you dental implants and teeth in a one-hour office visit. At an initial patient visit, doctors take a 3-D image of the patient’s jaw using an iCAT machine. When used with new computer software, the images show dentists the exact anatomy of the patient’s jaw, finding even the smallest amounts of bone. Dentists can plan the surgery with pinpoint accuracy using these images and eliminate any potential problems before the patient even arrives at the office for the procedure. 

Peter Wohrle from The Wohrle Dental Implant clinics in Newport Beach, California says, “with this new technique, we can treat patients more efficient, with less pain, and more accuracy” Most procedures are done by cutting open the gums. No cutting means less trauma and less pain for the patient. When the patient comes for their implants, it takes about an hour to insert the implants and attach the teeth. Dr. Wohrle says: What used to take months, we often can accomplish now within hours, with much less trauma and better results.”

 

Via EPR Network
More
Healthcare press releases